Shalby Ltd. · NSE:SHALBY
Shalby — Merger or Acquisition (May 2021)
11 slides from Shalby's merger presentation, May 17, 2021
Slide 1: Exchange filing cover letter for investor conference call
6 ' SHALB -HOSPITAL - May 17,2021 The Listing Department Corporate Service Department National Stock Exchange of India Ltd BSE Limited Scrip Code :SHALBY Scrip Code: 540797 Through : httos://www.connect2nse.com/LISTING/ Through : httu://Iistina.bseindia.com Sub: Schedule of lnvestor Conference call
Slide 2: Investor Conference Call
Investor Conference Call Elara Securities (India) Private Limited is pleased to invite you to a Conference Call with Shalby Limited represented by Dr. Vikram Shah, Chairman and Managing Director Mr. Prahlad Inani, Chief Financial Officer Dr. Nishita Shukla, Chief Operating Officer Mr. Babu Thomas, C
Slide 3: Shalby Acquires Implant Assets from Consensus Orthopedics
Shalby Acquires Implant Assets from Consensus Orthopedics May 17, 2021 SHALBY LIMITED (BSE CODE: 540797 I SHALBY, NSE CODE: SHALBY) A leader in Joint Replacement surgeries in India with an established chain of multi-specialty tertiary care hospitals.
Slide 4: Agenda
AGENDA 01 TRANSACTION OVERVIEW 02 CONSENSUS ASSETS 03 TRANSACTION STRUCTURE 04 BUSINESS LEADERSHIP 05 100 DAY PLAN 06 STRATEGIC RATIONALE 2
Slide 5: Transaction Overview
TRANSACTION OVERVIEW Shalby acquires selected implant assets from Consensus Orthopedics for a cash consideration of USD 11.45 million Transaction Overview Transaction Highlights ✓ Shalby has entered into a definitive agreement to ✓ Mr. Sushobhan Dasgupta appointed as Vice acquire certain assets from
Slide 6: Consensus Assets
CONSENSUS ASSETS The acquired assets are primarily comprised of inventory and plant and equipment ✓ Product inventory includes knee systems, mobile bearing knee systems, hip KNEE SYSTEM systems and revision knee systems ✓ The manufacturing plant and equipment consists of: o Machining & finishing: 60
Slide 7: Transaction Structure
TRANSACTION STRUCTURE The assets have been acquired by Shalby Advanced Technologies Inc, a wholly owned subsidiary of Mars Medical Devices which in turn is a wholly owned subsidiary of Shalby Shalby Limited USD 11.45 million Deal Consideration 100% Equity USD 3.35 million USD 12.65 million Mars Medi
Slide 8: Business Leadership
BUSINESS LEADERSHIP Shalby appointed Sushobhan Dasgupta as Vice Chairman and Global President of Shalby Limited and Daniel Hayes as the Chief Executive Officer of Shalby Advanced Technologies ✓ Sushobhan Dasgupta, former Vice President -Orthopedics, ✓ Daniel Hayes, former CEO and founder of Consensu
Slide 9: 100 Day Plan
100 DAY PLAN Management focused on implementing 100 day business plan ✓ Define vision, mission, operating norms and culture ✓ Establish governance mechanisms for SOP (implant and instruments forecasting) processes, sales and market reporting and data analytics ✓ Strengthen relationships with supplie
Slide 10: Strategic Rationale
STRATEGIC RATIONALE The strategic and financial rationale for this acquisition is compelling ✓ Internationally experienced management team appointed to lead Shalby’s implant International business Management Team ✓ Enables Shalby to procure quality implants at a competitive price for its own consump
Slide 11: Disclaimer and Contact Details
DISCLAIMER and CONTACT DETAILS No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as